Inception Return
(4/23/2014)
|
11.07 %
|
|
YTD Return
|
15.74 %
|
|
NAVPS
(5/17/2019)
|
$12.71
|
|
Change
|
($0.09) / -0.69 %
|
|
|
Growth of $10,000
(As of April 30, 2019)
|
|
MER
|
2.36 %
|
|
Assets ($mil)
|
$29.89
|
|
Rank (1Yr)
|
932/1018
|
|
Std Dev (3Yr)
|
12.23 %
|
|
Volatility Ranking (3Yr)
|
9/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or Back
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
5.50 %
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund seeks long-term capital growth and current income by investing primarily in U.S. equity securities that pay, or may be expected to pay, dividends. The Fund may also invest in other types of securities that distribute, or may be expected to distribute, income. Any proposed change in the fundamental investment objectives of the Fund must be approved by a majority of the votes cast at a meeting of the Fund's investors called for that purpose.
|
Management Co.
Mackenzie Financial Corporation
Managers
Darren McKiernan, Eugene Profis
|
|
Asset Allocation
(As of February 28, 2019)
|
Sector Allocation
(As of February 28, 2019)
|
Geographic Allocation
(As of February 28, 2019)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Allergan PLC | International Equity | Healthcare | European Union | 5.73% |
| Constellation Brands Inc | US Equity | Consumer Goods | United States | 5.65% |
| Nokia Oyj - ADR | International Equity | Telecommunications | European Union | 5.38% |
| United Technologies Corp | US Equity | Technology | United States | 4.92% |
| Dentsply Sirona Inc | US Equity | Healthcare | United States | 4.44% |
| Equifax Inc | US Equity | Industrial Services | United States | 4.21% |
| Northern Trust Corp | US Equity | Financial Services | United States | 4.13% |
| Linde PLC | International Equity | Basic Materials | European Union | 3.98% |
| Coty Inc | US Equity | Consumer Goods | United States | 3.91% |
| Sherwin-Williams Co | US Equity | Basic Materials | United States | 3.64% |
Performance Data
(As of April 30, 2019)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
2.90
|
8.85
|
7.22
|
15.74
|
4.56
|
10.54
|
11.08
|
-
|
|
Benchmark
|
4.52
|
11.80
|
12.11
|
16.35
|
18.69
|
17.47
|
16.25
|
16.68
|
|
Quartile Ranking
|
4
|
3
|
4
|
2
|
4
|
3
|
3
|
-
|
|
Calendar Return (%)
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
2010
|
2009
|
|
Fund
|
-11.70
|
13.52
|
11.79
|
14.43
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Benchmark
|
3.98
|
13.80
|
8.65
|
20.77
|
24.19
|
41.93
|
13.16
|
4.41
|
8.81
|
9.34
|
|
Quartile Ranking
|
4
|
2
|
1
|
3
|
-
|
-
|
-
|
-
|
-
|
-
|
MSCI ESG Fund Metrics (As of May 01, 2019)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.